⨯

  • 22 Oct 21

Redx Pharma PLC (LON:REDX) presenting at the Proactive One2One Virtual Forum - October 2021

Redx Pharma PLC (LON:REDX) presenting at the Proactive One2One Virtual Forum - October 2021

Redx Pharma Plc | REDX | 63.0 0 0%
Follow Company Follow Company

    • 39 views

 

Lisa Anson (CEO) presenting at the Proactive One2One Virtual Forum Redx is a biotech company focused on the discovery and development of novel targeted medicines for the treatment of cancer and fibrotic disease

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress

Companies: Redx Pharma Plc

Redx Pharma PLC's Lisa Anson updates on lead asset RXC004 and increased investment by Redmile

Companies: Redx Pharma Plc

Redx Pharma 'building on transactions and financing, focused on moving our pipeline forwards'

Companies: Redx Pharma Plc

Redx Pharma mark 'transformational year for the company with significant pipeline'

Companies: Redx Pharma Plc

Redx Pharma Chief Scientific officer Richard Armer presents RXC007 fibrosis drug programme

Companies: Redx Pharma Plc

Redx Pharma's chief medical officer talks Phase II study plans for lead programme RXC004

Companies: Redx Pharma Plc

Copyright © 2021 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top